Rodman David Malcom

CIK 00016726592 companiesRADNOR, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001672659

Recent Transactions

50 trades

Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-03-09$26.84/sh−2,171→ 82,489 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-03-09−2,171→ 23,876 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-03-09$16.00/sh+2,171→ 84,660 total
Award
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-19+38,400→ 82,489 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-19+51,300→ 51,300 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-17−417→ 5,417 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-17$15.44/sh+417→ 44,506 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-17$27.59/sh−417→ 44,089 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-13−4,166→ 100,001 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-13−3,541→ 127,501 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-13$10.20/sh+3,541→ 53,978 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-13$27.33/sh−4,166→ 50,437 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-13$27.33/sh−3,541→ 50,437 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-13$27.58/sh−6,348→ 44,089 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-13$14.25/sh+4,166→ 54,603 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-12$29.64/sh−521→ 50,437 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-12$28.94/sh−5,828→ 50,958 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-12$1.08/sh+6,349→ 56,786 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-12−6,349→ 31,743 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-09−2,171→ 26,047 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-09$16.00/sh+2,171→ 52,608 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-09$30.21/sh−2,171→ 50,437 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-20−416→ 5,834 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-20$32.10/sh−416→ 50,437 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-20$15.44/sh+416→ 50,853 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-12$32.32/sh−6,348→ 61,804 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-12−6,348→ 38,092 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-12$1.08/sh+6,348→ 68,152 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-09$16.00/sh+2,170→ 63,974 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-09$33.27/sh−2,170→ 61,804 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-09−2,170→ 28,218 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−67,473→ 108,334 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$35.53/sh−53,470→ 61,804 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−53,630→ 30,388 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$15.44/sh+10,121→ 107,347 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$1.08/sh+28,038→ 97,226 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$14.25/sh+67,473→ 254,519 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−28,038→ 44,440 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−10,121→ 6,250 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−26,069→ 134,584 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$34.83/sh−139,245→ 115,274 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$10.20/sh+26,069→ 133,416 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$16.00/sh+53,630→ 187,046 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-02−10,053→ 72,478 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-02−9,347→ 160,653 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$35.87/sh−70,037→ 69,188 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$1.08/sh+10,053→ 81,888 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-02−20,168→ 84,018 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$15.44/sh+3,629→ 85,517 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$16.00/sh+20,168→ 115,032 total

Companies

Recent Filings

Address

150 N. RADNOR CHESTER RD. SUITE F200

RADNOR, PA, 19087

View on SEC.gov